全文获取类型
收费全文 | 705篇 |
免费 | 29篇 |
国内免费 | 2篇 |
专业分类
儿科学 | 101篇 |
妇产科学 | 5篇 |
基础医学 | 61篇 |
临床医学 | 63篇 |
内科学 | 366篇 |
皮肤病学 | 2篇 |
神经病学 | 53篇 |
特种医学 | 6篇 |
外科学 | 16篇 |
综合类 | 4篇 |
预防医学 | 46篇 |
药学 | 12篇 |
肿瘤学 | 1篇 |
出版年
2022年 | 7篇 |
2021年 | 24篇 |
2020年 | 8篇 |
2019年 | 14篇 |
2018年 | 18篇 |
2017年 | 5篇 |
2016年 | 6篇 |
2015年 | 9篇 |
2014年 | 19篇 |
2013年 | 31篇 |
2012年 | 25篇 |
2011年 | 35篇 |
2010年 | 13篇 |
2009年 | 22篇 |
2008年 | 37篇 |
2007年 | 53篇 |
2006年 | 42篇 |
2005年 | 41篇 |
2004年 | 24篇 |
2003年 | 20篇 |
2002年 | 12篇 |
2001年 | 18篇 |
2000年 | 27篇 |
1999年 | 28篇 |
1998年 | 7篇 |
1997年 | 5篇 |
1996年 | 3篇 |
1995年 | 3篇 |
1994年 | 8篇 |
1992年 | 12篇 |
1991年 | 13篇 |
1990年 | 8篇 |
1989年 | 17篇 |
1988年 | 10篇 |
1987年 | 12篇 |
1986年 | 9篇 |
1985年 | 9篇 |
1983年 | 9篇 |
1980年 | 4篇 |
1979年 | 5篇 |
1975年 | 5篇 |
1974年 | 5篇 |
1973年 | 3篇 |
1972年 | 6篇 |
1971年 | 3篇 |
1970年 | 6篇 |
1969年 | 5篇 |
1968年 | 5篇 |
1967年 | 6篇 |
1965年 | 2篇 |
排序方式: 共有736条查询结果,搜索用时 15 毫秒
11.
Neurological Sciences - Optimal reperfusion strategies for M2 occlusion are still uncertain, with previous studies questioning benefit of mechanical thrombectomy (MT) over intravenous thrombolysis... 相似文献
12.
13.
In 13 patients with congestive heart failure we tested the acute hemodynamic effects of 5 vs. 10 mg felodipine tablets, in a double-blind, cross-over study. One hour after felodipine 5 mg, echocardiographic ejection fraction (%), cardiac index (thermodilution-ml/min/m2), and pulmonary wedge pressure (mm Hg) significantly changed (from 21 +/- 2 to 26 +/- 2, 2350 +/- 150 to 2790 +/- 160, 24 +/- 4 to 17 +/- 4) while they remained steady after felodipine 10 mg. The greatest stroke index increases were associated with felodipine 5 mg in 12 patients and 10 mg in 1 patient. Therefore we evaluated (open study) the long-term (2 months- 1 year) clinical and hemodynamic efficacy following the treatment with the acutely most effective dose (twice daily). After 2 months ejection fraction, cardiac index and pulmonary wedge pressure were respectively 24 +/- 2, 2550 +/- 150, and 18 +/- 4 (12 hours after the last drug administration, n = 11, P less than 0.02 from baseline). These parameters further increased one to two hours after the following administration of felodipine. Clinical improvement (reduction of 1 functional class, according to the New York Heart Association) was observed in 8/13 patients. These 8 patients participated to the one year follow-up. In 5 patients follow-up was interrupted because of acute cardiovascular events. However, before study interruption (5 patients) or ending (3 patients) clinical status did not worsen and ejection fraction remained higher than in the pretreatment period. Therefore, low dose felodipine might be used in the treatment of congestive heart failure. 相似文献
14.
Spironolactone improves lung diffusion in chronic heart failure. 总被引:1,自引:0,他引:1
Piergiuseppe Agostoni Alessandra Magini Daniele Andreini Mauro Contini Anna Apostolo Maurizio Bussotti Gaia Cattadori Pietro Palermo 《European heart journal》2005,26(2):159-164
AIMS: To evaluate whether anti-aldosteronic treatment influences lung diffusion (DLCO) in chronic heart failure (HF) patients. Spironolactone improves clinical conditions and prognosis in chronic HF and reduces connective tissue matrix turnover; DLCO abnormalities in chronic HF are related to increase in fibrosis and connective tissue derangement. METHODS AND RESULTS: Thirty stable chronic HF patients, with reduced DLCO (<80% of predicted), were randomly assigned to active treatment (25 mg spironolactone daily) or placebo in addition to conventional anti-failure treatment. They were evaluated by quality of life questionnaire, laboratory investigations, cardiopulmonary exercise test, and pulmonary function test, which included DLCO and membrane diffusing capacity (DM). The evaluation was done before treatment and 6 months after. Quality of life score and standard pulmonary function tests were not significantly affected by spironolactone, while active treatment increased DLCO due to an increase of DM (DLCO: 18.3+/-3.9 vs. 19.9+/-5.5 mL/min/mmHg; DM: 28.1+/-7.7 vs. 33.3+/-8.6 mL/min/mmHg) and peak oxygen consumption (peak VO2 16.8+/-1.9 vs.18.6+/-2.2 mL/min/kg). Increments of DLCO and peak VO2 were linearly related (R=0.849, P<0.001). CONCLUSION: These data show a positive effect of spironolactone on gas diffusion and exercise capacity suggesting a novel mechanism by which anti-aldosteronic drugs improve HF clinical condition and prognosis. 相似文献
15.
16.
Esther M. Wesselink MD Masieh Abawi MD PhD Nynke H. M. Kooistra MD PhD Teus H. Kappen MD PhD Pierfrancesco Agostoni MD PhD Marielle Emmelot-Vonk MD PhD Wietze Pasma PhD Wilton A. van Klei MD PhD Romy C. van Jaarsveld MSc Charlotte S. van Dongen MSc Pieter A. F. M. Doevendans MD PhD Arjen J. C. Slooter MD PhD Pieter R. Stella MD PhD 《Journal of the American Geriatrics Society》2021,69(11):3177-3185
17.
In vitro activity of human immunodeficiency virus protease inhibitors against Pneumocystis carinii 总被引:3,自引:0,他引:3
Atzori C Angeli E Mainini A Agostoni F Micheli V Cargnel A 《The Journal of infectious diseases》2000,181(5):1629-1634
Since 1996, the introduction of protease inhibitors (PIs) has led to a dramatic decrease of human immunodeficiency virus-related Pneumocystis carinii pneumonia. This effect is clearly due, in large part, to the induction of immune reconstitution by highly active antiretroviral therapy (HAART). However, it is conceivable that PIs had other beneficial effects, including direct activity against Pneumocystis. In this study, the occurrence of specific aspartyl proteases in Pneumocystis is described. These protease targets seemed to be affected in vitro by antiretroviral PIs. These data suggest intriguing implications for the possible antipneumocystis benefit of receiving indinavir, ritonavir, nelfinavir, or saquinavir during HAART. 相似文献
18.
Giuseppe G L Biondi-Zoccai Marzia Lotrionte Pierfrancesco Agostoni Antonio Abbate Massimiliano Fusaro Francesco Burzotta Luca Testa Imad Sheiban Giuseppe Sangiorgi 《European heart journal》2006,27(22):2667-2674
AIMS: The role of aspirin in patients with coronary artery disease (CAD) is well established, yet patients happen to discontinue aspirin according to physician's advice or unsupervised. We thus undertook a systematic review to appraise the hazards inherent to aspirin withdrawal or non-compliance in subjects at risk for or with CAD. METHODS AND RESULTS: Electronic databases were systematically searched (updated January 2006). Study designs, patient characteristics, and outcomes were abstracted. Pooled estimates for odds ratios (OR) were computed according to random-effect methods. From the 612 screened studies, six were selected (50,279 patients). One study (31,750 patients) focused on adherence to aspirin therapy in the secondary prevention of CAD, two studies (2594) on aspirin discontinuation in acute CAD, two studies (13,706) on adherence to aspirin therapy before or shortly after coronary artery bypass grafting, and another (2229) on aspirin discontinuation among patients undergoing drug-eluting stenting. Overall, aspirin non-adherence/withdrawal was associated with three-fold higher risk of major adverse cardiac events (OR=3.14 [1.75-5.61], P=0.0001). This risk was magnified in patients with intracoronary stents, as discontinuation of antiplatelet treatment was associated with an even higher risk of adverse events (OR=89.78 [29.90-269.60]). CONCLUSION: Non-compliance or withdrawal of aspirin treatment has ominous prognostic implication in subjects with or at moderate-to-high risk for CAD. Aspirin discontinuation in such patients should be advocated only when bleeding risk clearly overwhelms that of atherothrombotic events. 相似文献
19.
Early macronutrient intake and overweight at five years of age 总被引:2,自引:0,他引:2
Scaglioni S Agostoni C Notaris RD Radaelli G Radice N Valenti M Giovannini M Riva E 《International journal of obesity (2005)》2000,24(6):777-781
OBJECTIVE: To examine the influence of the macronutrient intake in early life on the development of overweight in children. DESIGN AND SUBJECTS: An ongoing longitudinal study including 147 randomized healthy children followed up from birth. MEASUREMENTS: Anthropometric parameters were measured at birth, 1 and 5 y of age. Dietary habits at the age of 1 and 5 were assessed by age-adjusted food-frequency questionnaires and 24 h recalls. Parents' body mass index (BMI) was also recorded. RESULTS: Parental overweight was observed for 51% children. The prevalence of overweight at the age of 5 y was higher in children with than without parental overweight (37.3% vs 8.3%, P<0.0001). Five-year old overweight children had a higher percentage intake of proteins at the age of 1 y than non overweight children (22% vs 20%, P=0.024) and lower intake of carbohydrates (44% vs 47%, P=0.031). Multiple logistic analysis confirmed that protein intake at 1 y of age was associated with overweight at 5 y (P=0.05). In children born from overweight mothers, prevalence of overweight at the age of 5 y tended to be higher in bottle-fed than in breast-fed ones (62.5% vs 23.3%, P=0.08). CONCLUSION: Parental overweight is a major risk factor for childhood overweight in the first years of life, but an early high protein intake may also influence the development of adiposity. 相似文献
20.
In untreated patients with uncomplicated essential hypertension, exercise induces an abnormal increase in blood pressure; the influences of this increase on exercise were evaluated by a cardiopulmonary exercise test (CPX) performed in control conditions (step 1) and during acute blood pressure reduction (step 2). Patients were classified as (1) normotensive (resting diastolic blood pressure [BPd] less than 90 mm Hg; n = 14), (2) mildly hypertensive (BPd of 90 to 104 mm Hg; n = 9), and (3) moderately to severely hypertensive (BPd greater than or equal to 105 mm Hg; n = 16). For the three groups, peak mean blood pressure during exercise was 125 +/- 5 mm Hg (mean +/- SEM), 144 +/- 3 mm Hg (p less than 0.01 vs normotensive), and 161 +/- 4 mm Hg (p less than 0.01 vs normotensive and p less than 0.01 vs mild hypertension), respectively. Oxygen consumption (VO2) at peak exercise and at ventilatory anaerobic threshold was 26.1 +/- 1.1 and 17.2 +/- 0.5 ml/min/kg, 25.4 +/- 1.1 and 16.9 +/- 0.8 ml/min/kg, and 26.4 +/- 1.3 and 17.5 +/- 1.2 ml/min/kg in normotensive subjects, those with mild hypertension, and those with moderate to severe hypertension, respectively. Fourteen normotensive subjects, six with mild hypertension, and nine with moderate to severe hypertension participated to step 2 (nifedipine vs placebo, double-blind crossover). Nifedipine reduced blood pressure at rest and at peak exercise in those with hypertension. Peak exercise VO2 was unaffected by nifedipine in both normotensive subjects and those with hypertension. With nifedipine, ventilatory anaerobic threshold occurred earlier and at a lower VO2 in mild and in moderate to severe hypertension (delta VO2 = -1.9 and -2.4 ml/min/kg, respectively). These findings might be due to nifedipine-induced redistribution of blood flow during exercise and might be the reason for the complaint of weakness after blood pressure reduction in hypertensive subjects. 相似文献